A commercial X-ray source with roots in SLAC research enables multi-mode computer tomography scans that outperform routine scans in hospitals. The technique could potentially find widespread use in medicine and other fields.

An experiment at SLAC's X-ray laser has revealed in atomic detail how a hypertension drug binds to a cellular receptor that plays a key role in regulating blood pressure.

Research reveals that the bacterial immune system can better destroy viral attackers by saving genetic records of previously encountered viruses.

Research performed in part at SLAC has provided new insights into how "TH proteins" couple two important processes needed to maintain healthy cells.

Understanding details of a flu antibody offers new insight for future structure-based drug discovery and novel avenues for designing vaccines.

Scientists at the Department of Energy’s SLAC National Accelerator Laboratory are combining the speed and precision of robots with one of the brightest X-ray lasers on the planet for pioneering studies of proteins important to biology and drug discovery.

A new experimental station in development at SLAC will expand capabilities for atomic-scale explorations in human health, biology, energy and environmental science.

Scientists at Genentech and SLAC have watched a key human protein change from a form that protects cells to one that kills them, providing valuable new insights to cancer research.

SSRL protein crystallography expert joined research effort that could lead to a safe and effective alternative to chemotherapy.

After working with particle accelerators his entire professional career, Heather Rock Woods’ father placed himself in the path of a beam to fight cancer.

By finding surprising similarities in the way immune system defenders bind to disease-causing invaders, a new study may help scientists develop new treatments.

Researchers have discovered that an Ebola virus protein can transform into three distinct structures with different functions. This rather uncommon property provides new clues for the development of potential drugs for deadly hemorrhagic fever.